Could Editas Medicine Become the Next CRISPR Therapeutics?

Could Editas Medicine Become the Next CRISPR Therapeutics?

Source: 
Motley Fool
snippet: 
  • Editas Medicine is a gene-editing biotech, just like CRISPR Therapeutics.
  • Editas has a long way to go before it'll be self-sustaining, and it might not get there.
  • It's also going to be facing down CRISPR Therapeutics as a major competitor.